CD4/CD8 double-negative T-cell lymphoma successfully treated with a combination of bexarotene and total skin electron beam therapy

J Dermatol. 2023 Jul;50(7):e210-e212. doi: 10.1111/1346-8138.16739. Epub 2023 Feb 5.

Authors

Ayano Tanigawa¹, Takeshi Fukumoto¹, Shinya Imamura¹, Korefumi Nakamura¹, Tomonori Tanaka², Tomoo Itoh², Eiji Nakano¹, Chikako Nishigori¹, Akiharu Kubo¹

Affiliations

¹ Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.
² Division of Pathology, Department of Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan.

PMID: 36740368
DOI: 10.1111/1346-8138.16739

No abstract available

Keywords: CD4/CD8 double-negative; T-cell lymphoma; bexarotene; total skin electron beam therapy.

Publication types

Case Reports
Letter

MeSH terms

Bexarotene / therapeutic use
CD8-Positive T-Lymphocytes
Electrons
Humans
Lymphoma, T-Cell, Cutaneous* / drug therapy
Lymphoma, T-Cell, Cutaneous* / radiotherapy
Male
Middle Aged
Skin Neoplasms* / drug therapy
Skin Neoplasms* / radiotherapy

Substances

Bexarotene